|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Interest-bearing deposits due from banks | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Debt Securities, Held-to-maturity | ||||||||||||||||||||
| Investment securities available for sale, at fair value (allowance for credit losses of $0 at March 31, 2024 and December 31, 2023) | ||||||||||||||||||||
| Investment securities held to maturity (fair value of $681,857 at March 31, 2024 and $702,563 at December 31, 2023 and allowance for credit losses of $146 at March 31, 2024 and December 31, 2023) | ||||||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||||||
| Federal Home Loan Bank and other membership bank stock, at cost | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans, net of deferred fees | ||||||||||||||||||||
| Less: Allowance for credit losses | ||||||||||||||||||||
| Total loans, net | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Federal funds purchased and securities sold under agreements to repurchase | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Federal Home Loan Bank of New York term borrowings | ||||||||||||||||||||
| Subordinated debentures | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Common stock, no par value; authorized 100,000,000 shares; issued 65,285,261 shares and outstanding 65,154,226 shares at March 31, 2024 and issued 65,161,310 shares and outstanding 65,030,275 shares at December 31, 2023 | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury shares, at cost, 131,035 shares at March 31, 2024 and December 31, 2023 | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Stockholders' Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Treasury shares (in shares) | ||||||||||||||||||||
Loading...
